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Abstract
Background: The use of tissue collected at a forensic post-mortem for forensic genetics research purposes remains
of ethical concern as the process involves obtaining informed consent from grieving family members. Two forensic
genetics research studies using tissue collected from a forensic post-mortem were recently initiated at our institution
and were the first of their kind to be conducted in Cape Town, South Africa.
Main body: This article discusses some of the ethical challenges that were encountered in these research projects.
Among these challenges was the adaptation of research workflows to fit in with an exceptionally busy service delivery
that is operating with limited resources. Whilst seeking guidance from the literature regarding research on deceased
populations, it was noted that next of kin of decedents are not formally recognised as a vulnerable group in the
existing ethical and legal frameworks in South Africa. The authors recommend that research in the forensic mortuary
setting is approached using guidance for vulnerable groups, and the benefit to risk standard needs to be strongly
justified. Lastly, when planning forensic genetics research, consideration must be given to the potential of uncovering
incidental findings, funding to validate these findings and the feedback of results to family members; the latter of
which is recommended to occur through a genetic counsellor.
Conclusion: It is hoped that these experiences will contribute towards a formal framework for conducting forensic
genetic research in medico-legal mortuaries in South Africa.
Keywords: Vulnerable group, Next of kin, Sudden unexpected death of infants, Suicide, Forensic, Post-mortem,
Medico-legal, Biomedical, Research ethics, South Africa
Background
The field of forensic genetics encompasses the analysis
of deoxyribonucleic acid (DNA) from human remains
for the purposes of identifying an individual or to help
understand their cause of death [1, 2]. Although the dis-
cipline has a strong service-orientated focus, research
and development play an important role in the improve-
ment of this evidence-based practice. Such research re-
quires the use of genetic material obtained from body
fluids and tissue, but the use of post-mortem material in
research is a sensitive subject. This is because taking in-
formed consent from grieving family members needs to
be strongly justified; there is the potential to do more
harm than good and to exploit a vulnerable population.
In this manuscript, we will describe some of the most
pertinent ethical challenges that we encountered in our
ongoing forensic genetics research.
The Division of Forensic Medicine and Toxicology
(DFMT) at the University of Cape Town (UCT) leads an
active role in service delivery, teaching and research
activities. UCT’s DFMT is closely affiliated with the
Department of Health, Western Cape Government,
which oversees the post-mortem investigation of individuals
whose deaths are deemed unnatural in the Western part of
the Cape Metropole of South Africa. Autopsies have been
performed for centuries and serve to establish the nature
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and extent of underlying natural disease, the process and
mechanism leading to death, and to enable learning,
teaching and research [3]. Post-mortem investigations,
from which we derive our genetic research samples,
are conducted at the Salt River Mortuary, which conducts
more than 3500 post-mortem examinations each year.
The DFMT hosts various research projects together with
those of the present authors.
Summary of studies
Over the past three years, we initiated two projects that
involve the use of post-mortem specimens for prospective
genetic analyses. The first involves an investigation of the
epidemiology, genetics and neurobiology of suicide. This
study seeks to identify multifactorial contributions to
suicidal behaviour. Part of this project involved the pilot
prospective collection and genetic testing of biological
material from suicide victims to establish whether single
nucleotide polymorphisms in candidate genes could pre-
dispose a person to commit suicide. This study completed
pilot sample collection in October 2015 and obtained in-
formed consent to collect brain tissue and/or blood from
37 out of 40 (92.5%) families during a one-year period.
The second study aims to explore the molecular basis
of sudden unexpected death in infants (SUDI) at Salt
River Mortuary. SUDI cases undergo post-mortem in-
vestigation in an attempt to establish cause of death.
Most of these cases at Salt River Mortuary end up being
classified as natural, with the leading cause of death be-
ing infection [4]. However, some deaths remain undeter-
mined and are thus classified as sudden infant death
syndrome (SIDS); which is defined when infants less
than one year old die suddenly and unexpectedly, and
the cause of death cannot be determined after thorough
post-mortem investigation, including a full autopsy,
death scene investigation and clinical history review [5].
Common risk factors for SUDI are typically environ-
mental, but despite awareness campaigns about these
risk factors in developed countries, there remains a re-
sidual burden of SUDI which suggests a genetic basis for
at least a component of these deaths [6]. This has led to
genetic testing in the form of molecular autopsies to try
and classify the cause of death, particularly in SIDS cases
[7]. These have taken on the form of genotyping known
mutations, sequencing candidate genes or massively par-
allel sequencing of exomes and genomes. Internationally,
this has shown potential in not only classifying the direct
genetic cause of death, but also establishing genetic fac-
tors that could predispose the infant during their critical
stage of development [7–11]. This project focuses on ex-
ploring whether specific genetic variants identified else-
where are also found in our population. The first sample
collection phase for the SUDI project was between
March 2016 and June 2016, where 38 families out of 40
(95%) gave informed consent for blood and/or buccal
swabs to be obtained from their deceased infants for
molecular analysis. Thus together, the researchers have
spoken to a total of 80 families during the pilot collec-
tion phases.
These two studies are among the first prospective mo-
lecular studies on deceased individuals conducted in
South Africa and as such are novel both to the research
regulatory infrastructure (including ethics committees)
and to the forensic services. One important secondary
function of these research projects is their role in estab-
lishing the feasibility and acceptability of carrying out
genetic research using post-mortem samples in South
Africa. While guidelines exist with regard to research of
this nature, most have limited applicability to low- and
middle- income countries (LMICs), where the access to
resources is severely limited [12, 13]. When speaking to
the 80 families of deceased individuals about collecting
samples for genetics research, and in seeking regulatory
approval for these studies, we noted some remarkable
similarities in our experiences, which are described and
discussed in the current manuscript.
Ethical considerations
As we planned and conducted our research, we encoun-
tered a number of ethical challenges, some of which
were anticipated and others that were not. To our sur-
prise, when looking to literature for guidance about how
to address these challenges, we found a scarcity of re-
sources to help us make sense of these challenges.
Institutional review board: Seeking approval
One of the first and arguably most challenging issues we
faced related to seeking ethics approval from our Human
Research Ethics Committee (HREC) for these studies. In
particular, when the first study was proposed – which
was also one of the first ever genetic studies on autopsy
samples reviewed by our Institutional Review Board –
we faced a barrage of critical questions that took over
two months to resolve. These included questions sur-
rounding feedback of results, incidental findings and the
timing of the consent, all of which are discussed in this
article. At the best of times, genomic research raises
fears and anxieties for ethics committees in Africa, relat-
ing importantly to the potential for exploitation and
concerns about identifiability [14]. We suspect that the
novelty of this research, combined with taboos sur-
rounding both suicide and SUDI and the fear that grief
could influence individuals’ ability to give informed con-
sent, made our HREC particularly anxious about the
proposed projects. We resolved this challenge by estab-
lishing a relationship with the ethics committee which
allowed for less formal conversations and explanations
to occur, specifically regarding the legal and judicial
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mandates under which medico-legal autopsies are per-
formed in the FPS in South Africa. Through this rela-
tionship, we worked with selected members of the
HREC to design a workable consent strategy for this
study. We also indicated that we would continue to en-
gage with the HREC about our experiences and alert
them to any particular challenges that may occur.
Informed consent: Process of procurement
Since both of these projects required samples to be collect
at the autopsy, informed consent needed to be obtained
prior to the autopsy taking place. According to the South
African National Health Act (Act 61 of 2003) and the
Inquests Act (Act 58 of 1959), it is mandated that all
deaths deemed to be unnatural are referred for a medico-
legal autopsy, and during this investigation, samples may
be retained at the discretion of the forensic pathologist,
for the purpose of determining cause of death.
Suicide, which is the intentional taking of one’s own
life [15], is considered an unnatural death, and therefore
requires a mandatory autopsy. SUDI, on the other hand,
is referred to for medico-legal autopsy under the cir-
cumstances that the death was sudden and unexpected
(National Health Act (Act 61 of 2003)); however, the
protocols for the post-mortem investigation of SUDI are
not standardised in South Africa [16, 17]. In the case of
autopsies, the South African laws allow for the obtaining
of tissue samples to determine cause of death, but not
for research purposes. Hence for these studies to occur,
informed consent must be obtained by the individual
concerned during their lifetime (or by a minor’s legal
guardian), or by their next of kin if the individual is
already deceased, to retain and use tissue for research
purposes [3]. This raises genuine ethical concerns which
need to be acknowledged and addressed.
There were also a number of important differences in
the consent processes for the two genetic studies we
conducted. The first of these is that while parents of in-
fants typically have legal authority to make decisions for
their infants, next-of-kin of adults do not normally have
such authority; although de facto they do make treat-
ment and/or research enrolment decisions on behalf of
their family members in some selected instances (e.g. in
the case of unconsciousness). In that case, next of kin
are approached on the assumption that they are best-
placed to make decisions on behalf of the individual and
may even have been made aware of the individual’s deci-
sions. In other words, for infants, we are asking parents to
make a decision based on their own belief system whilst
for next of kin of adults we are asking them to make a de-
cision based on what they think the deceased suicide vic-
tim would have wanted.
The second important difference relates to the ease
with which samples would be obtained during the autopsy.
In the case of suicide, autopsies are legally mandated (be-
cause the cause of death is considered ‘unnatural’) and sam-
ples may be obtained for ancillary testing in any case.
Seeking an additional sample for research in that process is
fairly straightforward. Not so in the case of SUDI. Without
evidence of ‘unnatural’ causes of death, the pathologist is
not legally mandated to establish the exact cause of natural
death and thus may not need to perform an internal/full
autopsy. In that case, the obtaining of a sample may consti-
tute the only surface violation of the corpse, and in the case
of very young infants, may require opening up the body to
obtain a blood sample from the heart. Since this sample
would not have been taken for cause of death determin-
ation, there is no legal mandate to take such a sample with-
out consent.
We based the design of our consent strategy on three
sources: discussions with the forensic pathology team
and the pathologist conducting the suicide genetic study;
discussions with the HREC; and on work reported by
Odendaal and colleagues [13]. Following these discus-
sions, we agreed that the most appropriate time to ob-
tain informed consent would be before the identification
process in a private designated interview. Family mem-
bers would normally only come to the mortuary once,
and for reasons of feasibility and cost, it was important
that we approached them at that point. The identifica-
tion process entails the formal identification of the de-
ceased by the next of kin for legal purposes, and is
typically an emotional process, accompanied by paper-
work. The researcher/s introduced themselves to the
next of kin of the deceased before the identification
process and expressed condolences to the family. Next
the researcher explained the project, which was also col-
lated into a written ‘information form’ which described
the purpose, background and procedure of the research
study. This form was approved by the Institutional Review
Board and contained the contact details of its chair and of
the researchers. Family members could participate volun-
tarily, and if they decided not to, there was no conse-
quence whatsoever – this was clearly explained to the
next of kin. The most common question asked by the next
of kin was if participating would delay the autopsy process
and eventual collection of their relative for the funeral.
It was explained to the next of kin that the collection of
additional samples would only take a few extra minutes.
Parents of infants who had demised suddenly and unex-
pectedly were given the option to only agree to a sam-
ple being taken if the pathologist decided to perform
an internal autopsy (and to leave the corpse intact
where he or she did not). In total, each informed con-
sent procedure took approximately 20–30 min.
If the family spoke a language that could not be
spoken by the researcher, a Forensic Pathology Officer
would translate; as such, we were able to communicate
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all major languages spoken in the Western Cape. In one
instance, a family spoke a dialect which none of the Fo-
rensic Pathology Officers could speak, and for fear of a
misunderstanding, it was decided to not approach them
for participation in the study. Similarly, if the consent
process became too distressing for the family member, it
was stopped immediately. In circumstances when reli-
gious leaders, such as the Imam, Rabbi or Hindu priest,
accompanied the family to the mortuary, it was decided
to include these religious leaders in the consent process
to (i) show respect the family wishes and (ii) to ensure
that members of these religious groups could also be in-
cluded in the study if they wished.
The researcher in the first study is a forensic patholo-
gist with over 10 years of experience and skill with deal-
ing with bereaved families of people on a daily basis.
During her specialist training, she developed the pre-
requisite skills to conduct consent for this research pro-
ject. The researcher in the second study is a biomedical
scientist who was specifically trained to talk to families
in stressful and emotional situations. Training took the
form of observations, role plays and debriefing sessions
conducted by a team of trained medical profes-
sionals, until the researcher was ready to take con-
sent on her own.
At the mortuary, managers can provide relief grief
counselling and support. If this was not adequate then
religious leaders were contacted to provide support. One
suggestion that emerged from our experiences was to
implement a better referral system for family members
to speak to qualified grief counsellors in their area, or at
Groote Schuur hospital, for a longer time after the iden-
tification process, which could be arranged on a case by
case basis.
Vulnerability: Recently bereaved individuals under study
South African laws and ethical guidelines define several
kinds of vulnerable groups that require special consider-
ation in research and beyond. In relation to research, the
Department of Health Ethical Guidelines (2015) define
vulnerable individuals as those whose willingness to
participate in research might be influenced either by an
expectation of benefit or by peer pressure [18]. In the
South African legislative and regulatory framework,
identified vulnerable groups include children, mentally
ill or disabled individuals, prisoners, subordinate mem-
bers of hierarchies, poor people, patients in emergency
situations and ethnic and racial minorities [19]. Neither
the South African ethical nor the legal frameworks
that describe or identify vulnerable groups explicitly
list deceased individuals and their living relatives as
vulnerable.
The Belmont Report (1979) introduced the idea of
“diminished autonomy”, whereby vulnerable groups
could be identified as those with a “dependent status”
and “inability or limited capacity to provide free con-
sent” [20]. In the case of deceased individuals, whether
they are children or adults, their capacity to provide
consent is non-existent, and they are completely
‘dependent’ on family members or their next of kin to
provide informed consent. But the important question is
whether the next of kin should not also be considered a
vulnerable group. In a period of profound grief, the next
of kin is given the added responsibility of making a deci-
sion with regards to consent for samples to be taken
from their child/family member/friend to be used for re-
search. Such individuals may or may not have a
“dependent status”; for example they might be subordin-
ate members of hierarchies, they might be poor individ-
uals or they might be from ethnic and racial minorities.
In these instances, they are vulnerable in one sense, but
does the fact that they are grieving make this population
a vulnerable group in their own right? While grief does
not strictly match the definition of a vulnerable group,
in our experience the capacity of grieving individuals to
freely give consent may be limited due to various rea-
sons including:
(i) The experience of shock and grief, both of which
could have impaired consenting adults’ ability to
understand the information provided;
(ii) An expectation that they ought to do everything
possible for their deceased and therefore give
consent without fully considering all aspects of the
research;
(iii)Pressures from their community to do what is
deemed ‘best’; this could be influenced by religion,
culture and what is perceived to be society’s norm;
(iv)They themselves want to know what happened
(peace of mind) and a molecular diagnosis could
relieve them from feeling guilty and/or defer them
blaming themselves for the death;
(v) Fear of what the results might reveal about their
parenting, in the case of SUDI cases or
interpersonal issues in the case of suicide.
From our perspective, the research participant is the de-
ceased individual as the biological sample was taken from
them; however, consent was given by their next of kin,
who – we propose – should be considered as vulnerable
in their own right due to their state of grief. Therefore, the
current definition of vulnerability is perhaps too narrow,
as it does not cater for other vulnerable groups who are
not participants themselves, but who are approached for
consent during a time in which they are vulnerable in the
same way that participants would be.
There is considerable discussion in bioethics on how
vulnerability should be understood and accounted for in
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research ethics [21]. What seems clear, however, is that
if vulnerability is understood as potentially impairing an
individual’s ability to give voluntary and informed con-
sent, then there is an argument for ‘special arrange-
ments’ to be put in place that promote the vulnerable
person’s ability to understand the information, and give
consent without undue pressure. This could, for in-
stance, involve deferral or progressive staging of consent,
where individuals are approached for initial consent but
then are approached for re-consenting when the factors
causing their vulnerability have resolved. A pertinent ex-
ample for our discussion is the enrolment of paediatric
emergency patients in research [22, 23]. The categorisa-
tion as a particular group of participants as ‘vulnerable’
thus seems to open up the possibility that consent pro-
cesses more explicitly take into account the circum-
stances of the person consenting. In our experience,
consenting grieving adults for enrolment in research,
when they have just lost a family member or child and
are awaiting autopsy is a really challenging, if not impos-
sible, task and that we should carefully consider more
appropriate ways of seeking consent from surviving rela-
tives, possibly over time.
A key feature of discussions around vulnerability is
that the exclusion of vulnerable groups from research
merely because it is inconvenient may be considered un-
ethical [18, 19]. Instead, research should also target vul-
nerable groups, but greater care should be taken to
specify the best interests of the population, and only re-
search that offers a direct benefit to the population
against acceptable risk should be conducted. It emerges
that a clear benefit for both the deceased population as
well as the family members needs to be clearly defined
in the research study.
Regarding the consenting family members as a vulner-
able group also highlights the need to ensure that they
are satisfied with the consent and research study over
time. Specifically, because of concerns about the con-
senting individual’s state of mind at the time of consent,
we think it is imperative to engage with those same fam-
ily members after some time has elapsed, to ensure they
are still satisfied with the consent they gave, have any
questions about the samples, and to give an update on
research progress.
While working with these vulnerable groups has gen-
erated concerns about potential exploitation, we have
also experienced a reaction of ‘empowerment’ by the
next of kin. Often, family members who are left behind
seem to blame themselves for the death, wonder what
they could have done to prevent the death and feel re-
sponsible for what happened. They feel very helpless fol-
lowing a death. The opportunity to participate in our
projects has, at times, given family members a sense of
hope and empowerment in that their family member
may not have died in vain, but could be seen as helping
others, through this research. The feeling of empower-
ment has been reported before in other studies including
vulnerable populations [24]. Hence, it is important to
appreciate the full spectrum of reactions from family
members and consequently to design mortuary-based
projects with these reactions/feelings/emotions in
mind.
Researcher’s emotional skills: Pressures of approaching
family members for conducting research
Research on this population is challenging and it places
considerable pressure on researchers, as speaking to
grieving family members about a research study is emo-
tionally and practically challenging for various reasons.
These include feelings of instability and uncertainty in
order to be available at unpredictable times to go to the
mortuary and meet the family, preparation for a wide
spectrum of responses from the family (individuals may
exhibit a blunted affect, be angry, crying or hysterical),
possessing skills to provide articulate information about
the research, as well as interview skills, whilst exhibiting
strength, patience, sympathy, adaptability, commitment,
knowledge, insight and credibility. Speaking to family
members who have just lost an infant, for instance, is ex-
ceptionally taxing and debriefing after every session is
essential for researchers who find themselves in similar
situations.
Because of the challenges relating to seeking consent
from recently bereaved family members, we consider the
following elements of good practice:
(i) Preference should be for individuals with prior
training in the forensic autopsy setting to seek
informed consent for such research;
(ii) Thorough training in how to communicate about
the research study is essential before researchers are
left to their own devices. Such training is labour-
and time-intensive and needs to be done carefully
and sensitively. For this reason, it is unlikely that
students or short-term research staff can be trained
appropriately and these should only be involved if
they already have some of the required skills or
experience necessary to communicate with grieving
family members appropriately;
(iii)Counselling support for researchers is essential to
help them develop coping mechanisms for dealing
with the effects of repeatedly engaging with the
trauma of families who have recently lost a family
member or infant;
Ideally, there should be a designated person at the
mortuary for all research studies but this may not be
feasible.
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Study feedback: Sharing results with family members
under study
When designing these studies, one important ethical
question that we considered was whether we should
share individual genetic research results with family
members; and if so, what results would be fed back. It
was decided that during the research phase of the stud-
ies, information will not be fed back to the families. This
was decided upon for various reasons; to work out pro-
ject logistics, burdens and hindrances; to prevent fam-
ilies from revisiting the trauma in what may be the
distant future; as well as due to the lack of clarity re-
garding what pathogenic mutations existed in the local
populations [25]; in other words the initial pilot research
was intended to be exploratory. Once clinically signifi-
cant mutations have been shown to underlie suicide and
SUDI, it is intended that a screening molecular assay will
be set up and validated to be offered prospectively as
part of the post-mortem investigation. In this instance, it
is envisaged that a genetic counsellor would be involved
to explain the significance of the genetic results with the
family. However, it is also possible that aspects of genetic
counselling may be introduced into the repertoire of
training of forensic pathologists and scientists involved
with molecular autopsies.
It is, however, imperative to make it clear in the in-
formed consent process, that the family members will
not receive feedback by participating in this research
study. It should also be explained that the study is un-
likely to benefit them or their family directly, but it is
hoped that it will contribute to knowledge about suicide
or SUDI in the future.
However, an unresolved challenge in our study is that
of deciding what to do if, during exome sequencing of
the deceased individual’s DNA, an unrelated mutation is
detected which would have implications on the living
family. An example would be a BRCA2 mutation which
is likely to have been inherited from the parent. The eth-
ical question is whether to inform the family of this mu-
tation or not? We have tentatively established a policy
that would allow us to return such findings if and only if
three criteria are met: a) the mutation must be medically
actionable; b) it must be unlikely that the condition
would have been diagnosed without the genetic finding,
and c) the mutations must have been validated across
multiple studies that are relevant to the South African
population [25]. Although we have not yet come across
this, it is important to consider what would be done in
such a case in the future. The anticipated challenges
here are manifold, but include: the funding of validation
studies, the availability and funding of a genetic
counsellor to feedback information to the family, and
also the challenge of contacting the bereaved family,
again, and with further ‘bad news’. These conditions and
limitations must be communicated to the family during
the initial, already challenging consent process, which at
this stage is exploring a wide range of issues. It is likely
that, as the project progresses, and the research team de-
velops, that the issue of unexpected findings may be
dealt with more comprehensively.
On another level, because of the vulnerability of the
consenting participants and because family members –
and particularly parents of SUDI – may never forget
about their child’s sample sitting in a laboratory some-
where, it is imperative that researchers are conscious of
the need for ongoing communication about study pro-
gress and generalised study findings. This could take the
form of e.g. an annual meeting for all research partici-
pants (which may have the added benefit of bringing to-
gether people with similar experiences), individual
genetic counselling sessions, or phone calls if and when
the project reveals new and important findings. In our
study, we intend to use a mix of all three approaches.
Conclusions
In order to accommodate these ethical concerns, we
have developed a number of practices that aim to ensure
forensic genetic studies are conducted without causing
unnecessary upset. These include some practices that
are part of good practice for research generally, and others
which are specific to conducting research on deceased in-
dividuals. With regard to the first, it is imperative that re-
searchers are transparent about the study – no matter
how difficult it is to speak with recently bereaved indi-
viduals. It is also essential to provide contact numbers
for the researchers, the ethics committee and also for
any support services that are available. Considering the
potential vulnerability of the family members, maintain-
ing confidentiality is key, as is providing information
about the study in the next of kin’s own language. Re-
cruitment processes need to be flexible enough to allow
a multitude of individuals to be involved in deciding on
research participation. This includes not only multiple
family members, but also, for instance, religious leaders
who accompany the family to the mortuary.
Specific to research being conducted on deceased indi-
viduals, we learned that it is important to provide study
information within the identification process, before
family members view the infant or suicide victim. It is
also important to ensure that the consent process takes
place in a suitable environment that is quiet and private –
and many mortuaries would have such suitable spaces.
Considering the emotional burden of working in these en-
vironments, it is imperative that researchers not only re-
ceive appropriate training to deal with the range of
emotions they may encounter, but that they also receive
counselling support to deal with any issue or stresses aris-
ing from this process. In addition, we advocate that
Heathfield et al. BMC Medical Ethics  (2017) 18:66 Page 6 of 8
projects should consider budgeting for grief counselling
support for family members, particularly considering that
such services are overstretched in South Africa and likely
to be so in other LMICs. Projects should also budget for
ongoing information meetings with participants enrolled
in the research projects, to update family members on
project progress and to reiterate the information provided
during the consent process. We would also advocate that
‘forensic genetic counselling’ is added to the training cur-
riculum of genetic counsellors and potentially other
medical genetics professionals.
We hope that our experiences will contribute to the de-
velopment of a framework for conducting research in mor-
tuaries in South Africa, especially as we get a better
understanding of the contribution of genetic factors to
death. This paper will feed into a meeting that we are
hoping to organise with relevant stakeholders from across
the country. During that meeting, we will aim to discuss
the ethical challenges of doing mortuary research, gain
broad input on the ways in which these challenges could be
addressed, and identify points of consensus that can form
the basis of a common approach to mortuary research.
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